Ratings by Raymond James (Tiago Fauth)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/24/2026 | Tonix Pharma | TNXP | New Coverage | Strong Buy (N/A) |
11.96 (12.43) |
3.93% | Details | |
| 6/24/2026 | MapLight Therapeutics | MPLT | New Coverage | Strong Buy (N/A) |
28.64 (37.87) |
32.23% | Details | |
| 5/7/2026 | Rapport Therapeutics | RAPP | Maintain | Strong Buy (N/A) |
|
Details | ||
| 4/9/2026 | PTC Therapeutics | PTCT | New Coverage | Outperform (N/A) |
71.26 (78.59) |
10.29% | Details | |
| 4/9/2026 | Praxis Precision Medicines Inc. | PRAX | New Coverage | Strong Buy (N/A) |
320.22 (314.41) |
-1.81% | Details | |
| 4/9/2026 | Jazz Pharmaceuticals | JAZZ | New Coverage | Outperform (N/A) |
195.93 (247.53) |
26.34% | Details | |
| 4/9/2026 | Ionis Pharmaceuticals | IONS | New Coverage | Outperform (N/A) |
74.98 (54.39) |
-27.46% | Details | |
| 4/9/2026 | Insmed | INSM | New Coverage | Outperform (N/A) |
160.18 (108.32) |
-32.38% | Details | |
| 4/9/2026 | Rapport Therapeutics | RAPP | New Coverage | Strong Buy (N/A) |
33.69 (42.62) |
26.51% | Details | |
| 4/9/2026 | United Therapeutics Corp. | UTHR | New Coverage | Outperform (N/A) |
581.69 (535.67) |
-7.91% | Details |
